XOMA: Expanding Royalty Portfolio and Capital-Efficient Partnerships Underpin Buy Rating
I'm PortAI, I can summarize articles.
Analyst Joseph Pantginis of H.C. Wainwright has maintained a Buy rating on XOMA with a price target of $97.00. His positive outlook is based on XOMA’s expanding royalty-based pipeline and strategic partnerships, including a collaboration with Takeda that adds nine programs without upfront costs. This enhances XOMA's long-term potential and diversifies its portfolio with late-stage assets. Pantginis believes this disciplined approach supports non-dilutive growth and justifies the Buy rating.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments